Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study on the Use of Ultra-stable Homogeneous Iodized Oil - Chemotherapy Drug Formulation for Sequential Thermal Ablation After TACE Treatment for Unresectable/ Unwilling-to-surgery-resected Early-stage Liver Cancer

NCT07493070 is registered in ClinicalTrials.gov with Fujian Medical University Union Hospital as lead sponsor.

NCT NCT07493070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07493070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study on the Use of Ultra-stable Homogeneous Iodized Oil - Chemotherapy Drug Formulation for Sequential Thermal Ablation After TACE Treatment for Unresectable/ Unwilling-to-surgery-resected Early-stage Liver Cancer
Lead sponsor
Fujian Medical University Union Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 10, 2026
Completion date
November 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)